Pharmacological blockade of serotonin 5-HT₇ receptor reverses working memory deficits in rats by normalizing cortical glutamate neurotransmission - Wikidata - awgldk - TriplyDB

Pharmacological blockade of serotonin 5-HT₇ receptor reverses working memory deficits in rats by normalizing cortical glutamate neurotransmission

Pharmacological blockade of serotonin 5-HT₇ receptor reverses working memory deficits in rats by normalizing cortical glutamate neurotransmission

http://www.wikidata.org/entity/Q33942069

about

Targeting the Serotonin 5-HT7 Receptor in the Search for Treatments for CNS Disorders: Rationale and Progress to Date Effects of the selective 5-HT7 receptor antagonist SB-269970 and amisulpride on ketamine-induced schizophrenia-like deficits in rats.AVN-101: A Multi-Target Drug Candidate for the Treatment of CNS Disorders.Pharmacological or genetic orexin1 receptor inhibition attenuates MK-801 induced glutamate release in mouse cortex.The role of serotonin in cognitive function: evidence from recent studies and implications for understanding depression.Ketamine and rapid-acting antidepressants: a window into a new neurobiology for mood disorder therapeutics Prepuberal stimulation of 5-HT7-R by LP-211 in a rat model of hyper-activity and attention-deficit: permanent effects on attention, brain amino acids and synaptic markers in the fronto-striatal interface.An Algorithm to Identify Target-Selective Ligands - A Case Study of 5-HT7/5-HT1A Receptor Selectivity.ADN-1184 a monoaminergic ligand with 5-HT(6/7) receptor antagonist activity: pharmacological profile and potential therapeutic utility.Serotonergic modulation of glutamate neurotransmission as a strategy for treating depression and cognitive dysfunction The role of serotonin in memory: interactions with neurotransmitters and downstream signaling.The 5-HT7 receptor as a potential target for treating drug and alcohol abuse.Hippocampal 5-HT7 receptors signal phosphorylation of the GluA1 subunit to facilitate AMPA receptor mediated-neurotransmission in vitro and in vivo.Development of CNS multi-receptor ligands: Modification of known D2 pharmacophores Emotional and risk seeking behavior after prepuberal subchronic or adult acute stimulation of 5-HT7-Rs in Naples High Excitability rats.Comparative effect of lurasidone and blonanserin on cortical glutamate, dopamine, and acetylcholine efflux: role of relative serotonin (5-HT)2A and DA D2 antagonism and 5-HT1A partial agonism.Positive association between neuroticism and working memory in healthy female volunteers.

P2860

Q28084125-CC75A70A-778F-45B2-B084-4E1AA47ED655 Q28533794-0D52AC92-5329-4BD8-9E8B-335913A875FD Q30377178-A7506074-415D-457E-A87D-CE1F50704D29 Q33659596-BDB40A59-E428-4EC7-9895-EF05238266FF Q34335586-658A2D9D-4863-4577-99FF-9CA1473508D5 Q34444632-AB5BD773-BC2E-4154-BDF9-8F810B008679 Q35141699-8B4B727B-3CB6-4824-AC5A-927FC26DE712 Q36043433-9EA3C018-A2EF-4CE8-9715-0650A25370D4 Q37585410-E021A130-9780-4121-B3BD-06BE6701ABC0 Q38125568-DFEDFCE7-8B14-4EB4-9A77-FE2D40123260 Q38178842-AC7C532C-ECA5-481D-8F83-16AFE4749871 Q38335136-0EBC7748-790A-4B0D-B924-BA18ADE89266 Q40160363-69377EC4-6C8D-454F-A1AD-75B2D58738FA Q40626733-99CAE0E6-37A6-432D-9046-7B6C60E46E53 Q42629945-770B2330-B8F3-43F1-A95D-2D52973EBFCD Q45145553-1C2ED4C5-1CC6-49C1-A2A7-7E6CF3DF1EC2 Q50634606-48810E6F-598C-4D68-80D5-37E35CE20EFA

P2860

Pharmacological blockade of serotonin 5-HT₇ receptor reverses working memory deficits in rats by normalizing cortical glutamate neurotransmission

http://www.wikidata.org/entity/Q33942069

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Pharmacological blockade of se ...... al glutamate neurotransmission

@ast

Pharmacological blockade of se ...... al glutamate neurotransmission

@en

type

label

Pharmacological blockade of se ...... al glutamate neurotransmission

@ast

Pharmacological blockade of se ...... al glutamate neurotransmission

@en

prefLabel

Pharmacological blockade of se ...... al glutamate neurotransmission

@ast

Pharmacological blockade of se ...... al glutamate neurotransmission

@en

P1433

Q33942069-1591C881-F166-4473-94A4-FEA67FE5054F

P1476

Q33942069-4190A4B3-3187-4B8C-A14A-C8FF4464286B

P2093

Q33942069-283F7F27-009C-4D06-A19F-A30FF83A70B5

Q33942069-2D998A2E-BBA5-4784-B346-271314D2E30B

Q33942069-34F83D8A-42FE-414F-94C0-2D26237B66A7

Q33942069-986B1535-05CA-43F8-9915-86C5FC145170

Q33942069-A8757676-7DEA-47AD-92B0-32AD340B45EB

Q33942069-E7BD8610-846B-4443-A4B5-7E8DBDFE4A06

Q33942069-E9882B6A-533F-4CD1-9F3F-50721414C31C

P2860

Q33942069-07841E8D-50F7-4BDB-B9FC-61DB996658CE

Q33942069-195CF76F-8855-4535-967C-1F85828B1E28

Q33942069-1C4E0A57-D594-4CB0-821B-26A1FD369537

Q33942069-216D10A9-318B-4800-873F-4E87B9A395A5

Q33942069-23D4109A-2D5B-45E2-A972-65FAF5863A92

Q33942069-285B4F5D-1514-4E01-8D0B-61E97A848D24

Q33942069-2BA6E2C0-6639-4B78-8938-F8DF20AD8ABE

Q33942069-3152BC8D-A3D5-483E-8C44-DCA559419687

Q33942069-31A1080C-35BE-4504-9320-E9F2685A4E90

Q33942069-435066E4-2FE2-4FF3-B41E-16C58E95B6A2

P304

Q33942069-BF77C44A-FB46-41C1-A730-6CA392CADAAB

P31

Q33942069-AAF23AC5-4BED-40AB-8BF0-35CF83FB9AFB

P356

Q33942069-AB23F144-F3B8-465F-9182-EFCD9691F216

P407

Q33942069-9F4C531A-46A2-430B-8898-141CC4627325

P433

Q33942069-30B3C13C-CB3D-467B-B41A-08BEDBCA15A5

P478

Q33942069-629D0F77-A741-4D43-B719-95CD63818934

P50

Q33942069-A6B0F29A-54EC-4E31-AFE8-B85229E8EA4B

P577

Q33942069-44AF28B9-6A60-408F-B819-EF8871A94157

P5875

Q33942069-71D482A0-70A0-41F8-8EBC-3F60DEB5ABFD

P698

Q33942069-09982675-E70D-4821-80F9-90600B98079B

P932

Q33942069-FD567E12-3A20-4703-ABDA-84BF50A5E711

P356

JOURNAL.PONE.0020210

P1433

P1476

Pharmacological blockade of se ...... al glutamate neurotransmission

@en

P2093

Brian Lord

http://www.w3.org/2001/XMLSchema#string

Ian C Fraser

http://www.w3.org/2001/XMLSchema#string

Jamin D Boggs

http://www.w3.org/2001/XMLSchema#string

Leah Aluisio

http://www.w3.org/2001/XMLSchema#string

Pascal Bonaventure

http://www.w3.org/2001/XMLSchema#string

Ruggero Galici

http://www.w3.org/2001/XMLSchema#string

Timothy W Lovenberg

http://www.w3.org/2001/XMLSchema#string

P2860

Serotonin 5-HT7 receptor agents: Structure-activity relationships and potential therapeutic applications in central nervous system disorders

A novel adenylyl cyclase-activating serotonin receptor (5-HT7) implicated in the regulation of mammalian circadian rhythms

NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development

Effect of 5-HT(7) antagonist SB-269970 in the modulation of working and reference memory in the rat

A 5-HT7 heteroreceptor-mediated inhibition of [3H]serotonin release in raphe nuclei slices of the rat: evidence for a serotonergic-glutamatergic interaction

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

Pharmacological blockade of 5-HT7 receptors as a putative fast acting antidepressant strategy

Inactivation of the 5-HT(7) receptor partially blocks phencyclidine-induced disruption of prepulse inhibition.

Effects of ketamine and N-methyl-D-aspartate on glutamate and dopamine release in the rat prefrontal cortex: modulation by a group II selective metabotropic glutamate receptor agonist LY379268.

The 5-HT(7) receptor as a mediator and modulator of antidepressant-like behavior.

P304

e20210

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0020210

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-06-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

238569757

http://www.w3.org/2001/XMLSchema#string

P698

21701689

http://www.w3.org/2001/XMLSchema#string

P932

3119073

http://www.w3.org/2001/XMLSchema#string